Y. Terui

869 total citations
29 papers, 687 citations indexed

About

Y. Terui is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Y. Terui has authored 29 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 12 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Y. Terui's work include Lymphoma Diagnosis and Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Y. Terui is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Y. Terui collaborates with scholars based in Japan, United Kingdom and India. Y. Terui's co-authors include Hiroyuki Nojiri, Kiyohiko Hatake, Yusuke Furukawa, Kengo Takeuchi, Masaru Yokoyama, Yuko Mishima, Masatsugu Ohta, Yasusada Miura, Shunji Takahashi and Masaki Saito and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Y. Terui

27 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y. Terui Japan	14	330	221	208	183	75	29	687
Huifeng Niu United States	13	362 1.1×	251 1.1×	290 1.4×	267 1.5×	149 2.0×	17	783
Cory Mavis United States	16	441 1.3×	120 0.5×	285 1.4×	245 1.3×	159 2.1×	74	754
Tohru Miki Japan	12	262 0.8×	334 1.5×	223 1.1×	284 1.6×	149 2.0×	28	832
Yvonne T.M. Tsang United States	18	533 1.6×	166 0.8×	329 1.6×	161 0.9×	148 2.0×	24	1.2k
Glenn Michelson United States	14	340 1.0×	112 0.5×	282 1.4×	136 0.7×	83 1.1×	51	668
Jennifer E. Amengual United States	15	574 1.7×	214 1.0×	408 2.0×	450 2.5×	137 1.8×	87	1.1k
Roger Mouawad France	21	523 1.6×	208 0.9×	308 1.5×	74 0.4×	27 0.4×	57	968
Archontoula Stoffel United States	12	548 1.7×	91 0.4×	259 1.2×	102 0.6×	56 0.7×	15	826
Melinda S. Gordon United States	10	394 1.2×	155 0.7×	195 0.9×	74 0.4×	66 0.9×	25	683
Frank Herting Switzerland	13	318 1.0×	165 0.7×	232 1.1×	176 1.0×	178 2.4×	28	712

Countries citing papers authored by Y. Terui

Since Specialization

Citations

This map shows the geographic impact of Y. Terui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Terui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Terui more than expected).

Fields of papers citing papers by Y. Terui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Terui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Terui. The network helps show where Y. Terui may publish in the future.

Co-authorship network of co-authors of Y. Terui

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Terui. A scholar is included among the top collaborators of Y. Terui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Terui. Y. Terui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Furusho, Aogu, Hajime Mizuno, Y. Terui, et al.. (2025). Mass spectrometric analysis of the amiodarone-induced alteration of phosphatidylcholines in living single cells. Journal of Pharmaceutical and Biomedical Analysis. 265. 117045–117045.

Yoshioka, Yasuo, Yuko Mishima, Noriko Nishimura, et al.. (2019). Assessment of Late Toxicities of Liver and Kidney after Definitive Radiotherapy for Gastric MALT Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 105(1). E475–E475. 1 indexed citations

Nishimura, Noriko, Reimi Asaka, Kengo Takeuchi, et al.. (2017). Quantitative analysis of MYD88 L265P mutations by digital PCR is an independent prognostic factor for CNS relapse as well as systemic relapse and poor outcome. Hematological Oncology. 35(S2). 277–277.

Yokoyama, Masaru, Y. Terui, Noriko Nishimura, et al.. (2017). Low absolute peripheral blood CD4+ T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma. Blood Cancer Journal. 7(4). e558–e558. 22 indexed citations

Nishimura, Noriko, Y. Terui, Atsushi Takahashi, et al.. (2015). Multiple myeloma as a second primary malignancy; one fourth of patients had prior history of other malignances. Clinical Lymphoma Myeloma & Leukemia. 15. e113–e113. 2 indexed citations

Terui, Y., et al.. (2015). CyBorD demonstrated its superiority to bortezomib plus dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma. Clinical Lymphoma Myeloma & Leukemia. 15. e262–e263. 1 indexed citations

Terui, Y., M. Yokoyama, Yuji Mishima, et al.. (2014). Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma. Haematologica. 100(1). 87–90. 15 indexed citations

Suzuki, Keigo, Y. Terui, Noriko Nishimura, et al.. (2012). Prognostic Value of C-reactive Protein, Lactase Dehydrogenase and Anemia in Recurrent or Refractory Aggressive Lymphoma. Japanese Journal of Clinical Oncology. 43(1). 37–44. 11 indexed citations

Mishima, Yuji, et al.. (2011). The identification of irreversible rituximab-resistant lymphoma caused by CD20 gene mutations. Blood Cancer Journal. 1(4). e15–e15. 18 indexed citations

10.

Kobayashi, Tsutomu, Junya Kuroda, Eishi Ashihara, et al.. (2010). Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways. Leukemia. 24(4). 843–850. 88 indexed citations

11.

Chìn, Keisho, Nobuyuki Mizunuma, Mariko Ogura, et al.. (2009). Circulating tumor cells (CTCs) as a surrogate marker for determining response to chemotherapy in advanced gastric cancer (AGC). Journal of Clinical Oncology. 27(15_suppl). 4600–4600. 1 indexed citations

12.

Kodaira, Makoto, Shunji Takahashi, Shuhei Yamada, et al.. (2009). Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy. Annals of Oncology. 21(6). 1163–1167. 20 indexed citations

13.

Ennishi, Daisuke, Masaru Yokoyama, Y. Terui, et al.. (2008). Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy. Annals of Oncology. 20(3). 526–533. 46 indexed citations

14.

Ennishi, Daisuke, Kengo Takeuchi, Masaru Yokoyama, et al.. (2008). CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy. Annals of Oncology. 19(11). 1921–1926. 67 indexed citations

15.

Abe, Takashi, Haruhide Shinzawa, Hiroto Wakabayashi, et al.. (2000). Value of Laparoscopic Microwave Coagulation Therapy for Hepatocellular Carcinoma in Relation to Tumor Size and Location. Endoscopy. 32(8). 598–603. 41 indexed citations

16.

Terui, Y., Hiroshi Tomizuka, Yuji Mishima, et al.. (1999). NH2-terminal pentapeptide of endothelial interleukin 8 is responsible for the induction of apoptosis in leukemic cells and has an antitumor effect in vivo.. PubMed. 59(22). 5651–5. 17 indexed citations

17.

Hatake, Kiyohiko, Hiroshi Tomizuka, Masahiro Ikeda, Y. Terui, & Yasusada Miura. (1998). Apoptosis-gene expression in hematopoietic system: normal and pathological conditions (Review).. International Journal of Molecular Medicine. 1(1). 121–9. 2 indexed citations

18.

Terui, Y., Yusuke Furukawa, Takao Sakai, et al.. (1996). Up-regulation of VLA-5 expression during monocytic differentiation and its role in negative control of the survival of peripheral blood monocytes. The Journal of Immunology. 156(5). 1981–1988. 31 indexed citations

19.

Furukawa, Yusuke, Y. Terui, Kumi Sakoe, et al.. (1995). Over‐expression and amplification of the CDC2 gene in leukaemia cells. British Journal of Haematology. 90(1). 94–99. 8 indexed citations

20.

Nojiri, Hiroyuki, et al.. (1986). Ganglioside GM3: an acidic membrane component that increases during macrophage-like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemic cell lines HL-60 and U937.. Proceedings of the National Academy of Sciences. 83(3). 782–786. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact